Inicio096530 • KOSDAQ
add
Seegene Inc
Cierre anterior
25.700,00 ₩
Intervalo diario
24.950,00 ₩ - 25.700,00 ₩
Intervalo anual
21.250,00 ₩ - 36.650,00 ₩
Cap. bursátil
1,31 B KRW
Volumen medio
187,83 mil
Relación precio-beneficio
-
Rentabilidad por dividendo
3,19 %
Bolsa de valores principal
KOSDAQ
En las noticias
Datos financieros
Estado de resultados
Ingresos
Ingresos netos
| (KRW) | sept 2025info | Cambio interanual |
|---|---|---|
Ingresos | 113,54 mil M | 4,34 % |
Gastos operativos | 61,51 mil M | -1,95 % |
Ingresos netos | 14,56 mil M | 772,99 % |
Margen de beneficio neto | 12,82 | 737,91 % |
Beneficios por acción | — | — |
EBITDA | 26,99 mil M | 17,37 % |
Tipo impositivo efectivo | 21,05 % | — |
Balance general
Activos totales
Responsabilidades totales
| (KRW) | sept 2025info | Cambio interanual |
|---|---|---|
Efectivo y a corto plazo | 563,36 mil M | 5,18 % |
Activos totales | 1,22 B | -2,65 % |
Responsabilidades totales | 214,46 mil M | -2,93 % |
Patrimonio total | 1,00 B | — |
Acciones en circulación | 46,11 M | — |
Precio-valor contable | 1,18 | — |
Rentabilidad económica | 1,98 % | — |
Retorno sobre capital | 2,11 % | — |
Flujo de caja
Variación neta del flujo de caja
| (KRW) | sept 2025info | Cambio interanual |
|---|---|---|
Ingresos netos | 14,56 mil M | 772,99 % |
Efectivo de operaciones | 37,18 mil M | -12,83 % |
Efectivo de inversión | -76,83 mil M | -113,10 % |
Efectivo de financiación | -14,75 mil M | 12,37 % |
Variación neta del flujo de caja | -48,33 mil M | -219,69 % |
Flujo de caja libre | 21,14 mil M | -18,94 % |
Información sobre la empresa
Seegene, Inc is a Korean manufacturer of in vitro diagnostic products, particularly molecular diagnostics. Its portfolio includes a range of assays and screening products for sepsis, respiratory diseases such as influenza and respiratory syncytial virus, as well as sexually transmitted infections. It was founded in 2000. In early 2020, it began developing and distributing a range of tests for SARS-CoV-2, the virus that causes COVID-19.
Along with its headquarters in Seoul, South Korea, the company has subsidiaries in the U.S., Canada, Germany, Italy, Mexico, Brazil, and the Middle East.
In September 2010, Seegene undertook a $16.6 million initial public offering to list on KOSDAQ, a trading board of Korea Exchange. Wikipedia
Director ejecutivo
Fundación
16 sept 2000
Sitio web
Empleados
215
